SQUAWK/NEWS
Menu
Live News EQUITY L impact

Alaunos Therapeutics Files SEC Form

Alaunos Therapeutics submits regulatory filing with the SEC. The filing is available for public review.

ALNS

Filed: 2026-05-27 AccNo: 0001193125-26-241999 Size: 4 KB